- Biora Therapeutics (NASDAQ:BIOR) has announced that the company has been granted an extension to regain compliance with Nasdaq listing requirements.
- “We shared with Nasdaq the upcoming company catalysts that we believe will drive significant value for shareholders, and we are pleased with their decision to grant us an extension to regain compliance,” said Adi Mohanty, CEO.
